Results 131 to 140 of about 19,727 (209)

Trends in Use of Direct-Acting Antivirals for Treatment of Hepatitis C Virus Infection in Australia 2016-2024. [PDF]

J Viral Hepat
Luong CL, Ellett LK, Pratt N, Staff K, Janetzki J.   +4 more
europepmc   +1 more source

Efficacy and safety of sofosbuvir-based therapies for treating HCV in children: observations from a real-world setting. [PDF]

Eur J Clin Microbiol Infect Dis
Pokorska-Śpiewak M, Dobrzeniecka A, Talarek E, Aniszewska M, Marczyńska M.   +4 more
europepmc   +1 more source

The Effectiveness of a Sofosbuvir/Daclatasvir Combination in the Treatment of HCV Infection in Patients from Mauritania Undergoing Chronic Hemodialysis. [PDF]

Medicina (Kaunas)
Mah SM, Sid'Ahmed S, Lemrabott M, Welli D, Awa J, Sidi Aly A, Rostaing L.   +6 more
europepmc   +1 more source

Safety and efficacy of different therapeutic regimens in Egyptian adults with moderate COVID-19 infection (EVEREST): a real-world retrospective study. [PDF]

Sci Rep
Abdel-Salam Elgohary M, Hamza N, Ali A, Zaher Abdel-Rahman R, Thabet Elnagar M, Emam Mohamed M, Seadawy MG, Zenhom Abdelfatah M, Taha NA, Rauof M, El-Bouseary MM.   +10 more
europepmc   +1 more source

Consideration of ledipasvir/sofosbuvir as an alternative to glecaprevir/pibrentasvir based upon on-treatment FIB-4 changes and sustained virologic response at 12 weeks in hepatitis C genotype 1 and 2 infections: A propensity score-matched study. [PDF]

Medicine (Baltimore)
Park HJ, Wang H, Jeong J, Seo KI, Shin JW, Park NH.   +5 more
europepmc   +1 more source

Stevens-Johnson syndrome associated with daclatasvir and sofosbuvir co-therapy in hepatitis C treatment: a rare case report. [PDF]

Ann Med Surg (Lond)
Sajjad W, Rehman UU, Inam A, Alam I, Ghafoor S, Razzaq HD, Khwajakhail T, Gillani SHMUD, Razzaq H, Qamar I, Ali R, Ullah Z.   +11 more
europepmc   +1 more source

Review article: hepatitis E—a concise review of virology, epidemiology, clinical presentation and therapy [PDF]

, 2017
Abravanel, Abravanel, Agrawal, Allweiss, Baechlein, Baylis, Baylis, Baylis, Baylis, Bendall, Berg, Bernuau, Blasco-Perrin, Borkakoti, Bose, Brassard, Brown, Chandra, Cleland, Colson, Cossaboom, Crossan, Crossan, Crossan, Dalton, Dalton, Dao Thi, Davern, Debing, Debing, Debing, Denzin, Ditah, Donnelly, Dremsek, Emerson, Emerson, Emerson, Fischer, Fogeda, Fontana, Galante, Garbuglia, Garde, Gerolami, Graff, Graff, Grierson, Hakze-van, Harritshoj, Hartl, Hauser, Hewitt, Holla, Hoofnagle, Huang, Huang, Huang, Hughes, Jilani, Kabrane-Lazizi, Kalia, Kamar, Kamar, Kamar, Kamar, Kamar, Kamar, Khuroo, Khuroo, Kokkinos, Koning, Koonin, Kumar, Kumar, Kuniholm, Lee, Li, Lozano, Mallet, Manka, Mansuy, Mansuy, Mansuy, Matsubayashi, Maunula, Meng, Moin, Nair, Nanda, Nidaira, Ollier, Pas, Passos-Castilho, Pavio, Peron, Pischke, Pischke, Pourbaix, Ratra, Rein, Renou, Said, Sauleda, Sayed, Schemmerer, Schielke, Schlosser, Schofield, Scobie, Sehgal, Servant-Delmas, Sharapov, Shrestha, Slot, Smith, Stramer, Suneetha, Surjit, Takahashi, Takahashi, Tavitian, Tei, Teshale, Tesse, Todt, Tyagi, Valk, Versluis, Vollmer, Wang, Wang, Wichmann, Wu, Yoo, Zaaijer, Zhang, Zhang, Zheng, Zhou   +139 more
core   +1 more source

Trends in Utilization and Costs Following a Hepatitis C Elimination Initiative. [PDF]

JAMA Netw Open
Tabah A, Basu A, Cox-North P, Zerzan-Thul J, Evaskus L, Sullivan D, Colson J, Huriaux E, Stockton J, Heidari O, Wiggins L, Chang S, Kohler P.   +12 more
europepmc   +1 more source

Reducing Small Molecule Adsorption in a PDMS-Based Microphysiological System of the Female Reproductive Tract via Parylene-C Coating to Improve Mechanistic Studies. [PDF]

ACS Appl Mater Interfaces
Cherukuri R, Kim S, Moyer HL, Jesse H, Lam PY, Richardson LS, Kammala AK, Menon R, Rusyn I, Han A.   +9 more
europepmc   +1 more source

Hepatitis C Management in a Lung Cancer Patient on Checkpoint Inhibition: A Case Report. [PDF]

Cureus
Póvoas D, Garrido P, Moraes-Fontes MF, Manata MJ, Maltez F.   +4 more
europepmc   +1 more source